[{"Assets_0_Q2_USD":1507145000.0,"EarningsPerShareBasic_1_Q2_USD":0.79,"EarningsPerShareBasic_2_Q2_USD":1.32,"EarningsPerShareDiluted_1_Q2_USD":0.77,"EarningsPerShareDiluted_2_Q2_USD":1.28,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":84029000.0,"NetIncomeLoss_1_Q2_USD":42041000.0,"NetIncomeLoss_2_Q2_USD":69530000.0,"StockholdersEquity_0_Q2_USD":699570000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":54839000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":54466000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":52929000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":52804000.0,"Ticker":"NUS","CIK":"1021561","name":"NU SKIN ENTERPRISES INC","OfficialName":"Nu Skin Enterprises Inc. Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2429332607.0","Country":"United States","Sector":"Health Care","Industry":"Other Pharmaceuticals","Market":"NYSE","SP500":"nan","filed":"20170803"}]